Apyx Medical Corp (APYX)
1.60
+0.07
(+4.58%)
USD |
NASDAQ |
May 17, 16:00
1.65
+0.05
(+3.12%)
After-Hours: 20:00
Apyx Medical Cash from Financing (Quarterly): -0.005M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.005M |
| December 31, 2023 | 23.84M |
| September 30, 2023 | 0.164M |
| June 30, 2023 | 0.046M |
| March 31, 2023 | 8.112M |
| December 31, 2022 | -0.01M |
| September 30, 2022 | 0.127M |
| June 30, 2022 | 0.002M |
| March 31, 2022 | 0.098M |
| December 31, 2021 | -0.039M |
| September 30, 2021 | -0.033M |
| June 30, 2021 | 0.157M |
| March 31, 2021 | -0.061M |
| December 31, 2020 | -0.134M |
| September 30, 2020 | 0.109M |
| June 30, 2020 | -0.063M |
| March 31, 2020 | 0.015M |
| December 31, 2019 | -0.005M |
| September 30, 2019 | 0.037M |
| June 30, 2019 | 0.048M |
| March 31, 2019 | 0.067M |
| December 31, 2018 | 0.137M |
| September 30, 2018 | -2.509M |
| June 30, 2018 | -0.06M |
| March 31, 2018 | -0.06M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.06M |
| September 30, 2017 | -0.06M |
| June 30, 2017 | -0.06M |
| March 31, 2017 | -0.059M |
| December 31, 2016 | 5.715M |
| September 30, 2016 | 0.059M |
| June 30, 2016 | 0.001M |
| March 31, 2016 | -0.061M |
| December 31, 2015 | -0.059M |
| September 30, 2015 | -0.099M |
| June 30, 2015 | 1.229M |
| March 31, 2015 | 11.71M |
| December 31, 2014 | -0.289M |
| September 30, 2014 | 0.017M |
| June 30, 2014 | -0.786M |
| March 31, 2014 | -0.086M |
| December 31, 2013 | 6.941M |
| September 30, 2013 | -0.011M |
| June 30, 2013 | -0.028M |
| March 31, 2013 | -0.016M |
| December 31, 2012 | -0.033M |
| September 30, 2012 | -0.033M |
| June 30, 2012 | -0.032M |
| March 31, 2012 | -0.032M |
| December 31, 2011 | -0.197M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.134M
Minimum
Dec 2020
23.84M
Maximum
Dec 2023
1.620M
Average
0.026M
Median
Cash from Financing (Quarterly) Benchmarks
| Nortech Systems Inc | 0.274M |
| Monogram Orthopaedics Inc | 0.1507M |
| Perspective Therapeutics Inc | 166.33M |
| Xtant Medical Holdings Inc | 5.179M |
| Asensus Surgical Inc | 0.811M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.341M |
| Cash from Investing (Quarterly) | -0.035M |
| Free Cash Flow | -10.17M |
| Free Cash Flow Per Share (Quarterly) | -0.184 |
| Free Cash Flow to Equity (Quarterly) | -6.597M |
| Free Cash Flow to Firm (Quarterly) | -5.469M |
| Free Cash Flow Yield | -18.35% |